Literature DB >> 2155592

Survival after conservative resection for T1 N0 M0 non-small cell lung cancer.

R C Read1, G Yoder, R C Schaeffer.   

Abstract

Two hundred forty-four veterans, with a mean age of 62.4 years, mainly asymptomatic (pulmonary), were admitted generally for other disease or pension evaluation and underwent lobectomy (131), segmentectomy (107), or wedge resection (6) for T1 N0 M0 lung cancer between 1966 and 1988. Conservative resection was preferred during the past decade. The average lesion diameter was 2 cm. Thirty-day mortality was 2.9%, similar for the three procedures. Absolute 5-year survival, 51%, was 78% if only deaths from the initial lesion are considered; 19% died of comorbidity, and 8% died of second lung cancers. Routine preoperative computed tomographic staging and intraoperative sampling of even normal-sized hilar and mediastinal nodes, conducted after 1982, improved survival (p less than 0.006). Patients with lesions less than 2 cm in diameter (146) did better (p less than 0.04), and those with squamous tumors improved similarly (p less than 0.02). Lesions that communicated with a bronchus (88) were more malignant than those (156) that did not (p less than 0.02), because from that locus undifferentiated nonsquamous tumors metastasized widely. These results suggest that the T1 N0 M0 category is not uniform. Histology, size, and location in the lung are significant variables. Results of conservative resection were similar or better than those of lobectomy. The latter was used more in deep-seated lesions, however, when major intersegmental planes were transgressed, and before modern preoperative and intraoperative staging. The T1 N0 M0 category should include lesions 2 cm or less in diameter as a discrete entity.

Entities:  

Mesh:

Year:  1990        PMID: 2155592     DOI: 10.1016/0003-4975(90)90242-x

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  21 in total

1.  Analysis of feasibility and safety of complete video-assisted thoracoscopic resection of anatomic pulmonary segments under non-intubated anesthesia.

Authors:  Zhihua Guo; Wenlong Shao; Weiqiang Yin; Hanzhang Chen; Xin Zhang; Qinglong Dong; Lixia Liang; Wei Wang; Guilin Peng; Jianxing He
Journal:  J Thorac Dis       Date:  2014-01       Impact factor: 2.895

2.  Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non-small-cell lung cancer: a propensity-matched analysis.

Authors:  Rodney J Landreneau; Daniel P Normolle; Neil A Christie; Omar Awais; Joseph J Wizorek; Ghulam Abbas; Arjun Pennathur; Manisha Shende; Benny Weksler; James D Luketich; Matthew J Schuchert
Journal:  J Clin Oncol       Date:  2014-06-30       Impact factor: 44.544

3.  Segmentectomy versus lobectomy for stage I non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Benedetta Bedetti; Luca Bertolaccini; Raffaele Rocco; Joachim Schmidt; Piergiorgio Solli; Marco Scarci
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

Review 4.  Is limited pulmonary resection equivalent to lobectomy for surgical management of stage I non-small-cell lung cancer?

Authors:  Maya K De Zoysa; Dima Hamed; Tom Routledge; Marco Scarci
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-02-27

Review 5.  Surgical Management of Lung Cancer: History, Evolution, and Modern Advances.

Authors:  Abbas E Abbas
Journal:  Curr Oncol Rep       Date:  2018-11-13       Impact factor: 5.075

6.  Unidirectionally thoracoscopic resection of lingual segment of the left upper pulmonary lobe.

Authors:  Kaican Cai; Siyang Feng; Hua Wu; Yuanyuan Wang; Hancheng Zhao; Pengfei Ren; Ziliang Zhang
Journal:  J Thorac Dis       Date:  2014-09       Impact factor: 2.895

Review 7.  Meta-analysis of intentional sublobar resections versus lobectomy for early stage non-small cell lung cancer.

Authors:  Christopher Cao; Sunil Gupta; David Chandrakumar; David H Tian; Deborah Black; Tristan D Yan
Journal:  Ann Cardiothorac Surg       Date:  2014-03

Review 8.  Primary Treatment Options for High-Risk/Medically Inoperable Early Stage NSCLC Patients.

Authors:  Guy C Jones; Jason D Kehrer; Jenna Kahn; Bobby N Koneru; Ram Narayan; Tarita O Thomas; Kevin Camphausen; Minesh P Mehta; Aradhana Kaushal
Journal:  Clin Lung Cancer       Date:  2015-04-23       Impact factor: 4.785

9.  Analysis of lobectomy for small peripheral lung cancer supports extended segmentectomy.

Authors:  T Sakamoto; N Tsubota; Y Miyamoto; M Yoshimura
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-04

10.  Prediction of true-negative lymph node metastasis in clinical IA non-small cell lung cancer by measuring standardized uptake values on positron emission tomography.

Authors:  Tomoyoshi Takenaka; Tokujiro Yano; Yosuke Morodomi; Kensaku Ito; Naoko Miura; Daigo Kawano; Fumihiro Shoji; Shingo Baba; Koichiro Abe; Hiroshi Honda; Yoshihiko Maehara
Journal:  Surg Today       Date:  2012-08-03       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.